Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...

The Congressional Budget Office found that only one out of the seven policies it reviewed would create notable reductions in ...

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...

Bausch + Lomb has teamed up with American sportscaster Erin Andrews to promote its dry eye disease treatment, launching the ...

While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

Eversana is increasing its reach across the global pharmaceutical industry. | Eversana is increasing its reach across the ...

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...

A new survey commissioned by Big Pharma Roche has found that half of those polled “have either limited or no awareness” of ...

Spherix Global Insights said AbbVie’s Skyrizi has quickly blasted past Eli Lilly’s Omvoh in ulcerative colitis, ...

In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly ...

Off the scrapheap of discarded drugs and on its way to becoming the most highly anticipated approval of 2024, Bristol Myers ...

Afton Scientific, a CDMO, plans to shell out $200 million to expand its manufacturing plant in Charlottesville, Virginia, as ...